| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |